CS logo
small CS logo
University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology

Duesseldorf, NRW, Germany

About University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
2
Heinrich-Heine University, Duesseldorf
2
Total Rows: 2

Clinical Trials at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology


During the past decade, University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years220000110011000000000000Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
2015-09-15
2019-05-24
Completed
28
Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT
2015-05-01
2020-04-23
Completed
50

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" #1 collaborator was "Celgene Corporation" with 2 trials as a collaborator and "Koordinierungszentrum für Klinische Studien Düsseldorf" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 2Celgene: 2Heinrich-HeineUniversity, Duesseldorf:2Heinrich-HeineUniversity, Duesseldorf:2

Created with Highcharts 11.1.0Top CollaboratorsCelgene Corporation: 2Celgene Corporation: 2Koordinierungszentrumfür Klinische StudienDüsseldorf: 1Koordinierungszentrumfür Klinische StudienDüsseldorf: 1

Clinical Trials Conditions at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology


According to Clinical.Site data, the most researched conditions in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" are "Leukemia, Myeloid, Acute" (2 trials), "Myelodysplastic Syndromes" (2 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "IDH2 Gene Mutation" (1 trials) and "IDH2 R140" (1 trials). Many other conditions were trialed in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" in a lesser frequency.

Clinical Trials Intervention Types at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology


Most popular intervention types in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" are "Drug" (3 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (2 trials), "Donor Lymphocyte Infusions" (1 trials), "Enasidenib" (1 trials), "Gene-modified (GM) T cell therapy" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology


The vast majority of trials in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology" are 4 trials for "All" genders.

Clinical Trials Status at University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology


Currently, there are NaN active trials in "University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 4Phase 2: 4Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1